924 related articles for article (PubMed ID: 19167378)
1. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
2. CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness.
Herrera-Gayol A; Jothy S
Exp Mol Pathol; 1999 Apr; 66(1):99-108. PubMed ID: 10331969
[TBL] [Abstract][Full Text] [Related]
3. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
Afify AM; Craig S; Paulino AF; Stern R
Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
[TBL] [Abstract][Full Text] [Related]
4. Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
Xu FJ; Stack S; Boyer C; O'Briant K; Whitaker R; Mills GB; Yu YH; Bast RC
Clin Cancer Res; 1997 Sep; 3(9):1629-34. PubMed ID: 9815853
[TBL] [Abstract][Full Text] [Related]
5. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: I. In vitro studies of adhesion, migration and invasion of MDA-MB 231 human breast cancer cells.
Tantivejkul K; Vucenik I; Shamsuddin AM
Anticancer Res; 2003; 23(5A):3671-9. PubMed ID: 14666663
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronidase can modulate expression of CD44.
Stern R; Shuster S; Wiley TS; Formby B
Exp Cell Res; 2001 May; 266(1):167-76. PubMed ID: 11339835
[TBL] [Abstract][Full Text] [Related]
7. Adhesion proteins in the biology of breast cancer: contribution of CD44.
Herrera-Gayol A; Jothy S
Exp Mol Pathol; 1999 Jun; 66(2):149-56. PubMed ID: 10409443
[TBL] [Abstract][Full Text] [Related]
8. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
[TBL] [Abstract][Full Text] [Related]
9. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
Welsh CF; Zhu D; Bourguignon LY
J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
Fichtner I; Dehmel A; Naundorf H; Finke LH
Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of CD44 variant (v10/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis.
Iida N; Bourguignon LY
J Cell Physiol; 1997 May; 171(2):152-60. PubMed ID: 9130462
[TBL] [Abstract][Full Text] [Related]
12. The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer.
Udabage L; Brownlee GR; Nilsson SK; Brown TJ
Exp Cell Res; 2005 Oct; 310(1):205-17. PubMed ID: 16125700
[TBL] [Abstract][Full Text] [Related]
13. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
Afify A; Lynne LC; Howell L
Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
15. CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).
Wang HS; Hung Y; Su CH; Peng ST; Guo YJ; Lai MC; Liu CY; Hsu JW
Exp Cell Res; 2005 Mar; 304(1):116-26. PubMed ID: 15707579
[TBL] [Abstract][Full Text] [Related]
16. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells.
Draffin JE; McFarlane S; Hill A; Johnston PG; Waugh DJ
Cancer Res; 2004 Aug; 64(16):5702-11. PubMed ID: 15313910
[TBL] [Abstract][Full Text] [Related]
17. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix.
Zhu H; Mitsuhashi N; Klein A; Barsky LW; Weinberg K; Barr ML; Demetriou A; Wu GD
Stem Cells; 2006 Apr; 24(4):928-35. PubMed ID: 16306150
[TBL] [Abstract][Full Text] [Related]
18. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma.
Diaz LK; Zhou X; Wright ET; Cristofanilli M; Smith T; Yang Y; Sneige N; Sahin A; Gilcrease MZ
Clin Cancer Res; 2005 May; 11(9):3309-14. PubMed ID: 15867228
[TBL] [Abstract][Full Text] [Related]
19. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.
Harrison GM; Davies G; Martin TA; Mason MD; Jiang WG
Oncol Rep; 2006 Jan; 15(1):199-206. PubMed ID: 16328056
[TBL] [Abstract][Full Text] [Related]
20. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.
Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U
Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]